Dental Devices include products used for diagnosis of dental ailments and for dental treatment such as oral prophylaxis, dental surgical and restorative interventions. The CAD/CAM Systems and Materials category includes CAD/CAM Systems and CAD/CAM Materials. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cad/cam systems and materials devices market, including market shares of different players within Norway. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the cad/cam systems and materials market in Norway was Dentsply Sirona followed by Envista, Planmeca, 3Shape, GC America, 3M, Kuraray Noritake Dental, Roland DGA and Carestream Dental.
CAD/CAM Dental Systems consist of a 3D scanner, CAD/CAM Software and a milling device. CAD/CAM Disc Materials includes CAD/CAM Metal Disc Materials, CAD/CAM Ceramic Disc Materials and CAD/CAM Polymer Disc Materials.
The value of the cad/cam systems and materials devices market within Norway was expected to be over $20m in 2023.
For the latest complete market share analysis of cad/cam systems and materials device market in Norway, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
